Search filters

List of works by Paul M Barr

A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma.

scientific article

Adenosine depresses transmitter release but is not the basis for 'tetanic fade' at the neuromuscular junction of the rat

scientific article published on 01 July 1997

Antiangiogenic activity of thalidomide in combination with fludarabine, carboplatin, and topotecan for high-risk acute myelogenous leukemia

scientific article

Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK inhibition as an Effective Strategy

scientific article published on 20 March 2020

Cellular Cytotoxicity of Next-Generation CD20 Monoclonal Antibodies

scientific article published on 08 August 2018

Correlation between ZAP-70, phospho-ZAP-70, and phospho-Syk expression in leukemic cells from patients with CLL.

scientific article

Deregulation of NF-κB, ie, a useful PMBL marker

scientific article

Efficacy in the margins of NHL with ibrutinib

scientific article published in April 2017

Emerging protein kinase inhibitors for the treatment of non-Hodgkin's lymphoma

scientific article published on 24 June 2014

Flavopiridol: Judged by the company one keeps

scientific article published on 8 July 2013

Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia.

scientific article published on 06 February 2013

Getting to the heart of the problem in treating diffuse large B-cell lymphoma

scientific article published on 25 May 2011

Ibrutinib Dose Adherence and Therapeutic Efficacy in Non-Hodgkin Lymphoma: A Single-Center Experience

scientific article published on 13 October 2018

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia ⬇️

scientific article

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia

scientific article

Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

scientific article published on 01 August 2019

Impact of dietary supplements, obesity and treatment initiation on serum vitamin D levels in patients with lymphoma

scientific article published on 15 July 2014

Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL.

scientific article

Infection in chronic lymphocytic leukemia: parsimony has its limits

scientific article published on 16 May 2014

Management of melanoma in patients with chronic lymphocytic leukemia

scientific article published on 06 July 2018

Non-Hodgkin's lymphoma in the elderly

scientific article published in March 2010

Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium

scientific article

Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas

scientific article published on 18 August 2015

Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL.

scientific article published on 11 March 2016

Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma

scientific article

Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108.

scientific article

Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant.

scientific article published on August 2009

Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma

scientific article published on 06 August 2011

Postibrutinib outcomes in patients with mantle cell lymphoma

scientific article

Regression of CD30+ cutaneous anaplastic large-cell lymphoma with denileukin diftitox

scientific article published on 01 June 2011

Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma

scientific article published on 30 October 2020

Spontaneous autologous graft-versus-host disease in plasma cell myeloma autograft recipients: flow cytometric analysis of hematopoietic progenitor cell grafts

scientific article published on 11 April 2011

Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion

scientific article

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.

scientific article published on 20 July 2015

Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor.

scientific article

The ABC of chronic lymphocytic leukemia: etiology of cytopenias is important in staging and management

scientific article published in November 2013

The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia.

scientific article published on 9 March 2015

The role of bortezomib in the treatment of lymphoma.

scientific article published on December 2007

Toxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma

scientific article published on 25 October 2020

Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice

scientific article published on 19 April 2019

Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia

scientific article published on 10 February 2019

Updated Efficacy and Safety from the Phase 3 Resonate-2 Study: Ibrutinib As First-Line Treatment Option in Patients 65 Years and Older with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia

Scientific article published on 2 Dec 2016

Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial

scientific article published on 12 December 2017

Paulina is supported by:

About Paulina

Help